RETN and hypertensive disorder: Recently, Koh et al. reported that amlodipine (a calcium channel blocker) therapies significantly decreased resistin levels greater than ramipril (an angiotensin-converting enzyme inhibitor) or candesartan (an angiotensin II receptor antagonist) therapies in patients with hypertension [31].